Saudi Arabia vs Timor-Leste: Treatment success rate for patients treated for MDR-TB
Saudi Arabia
93.0%
in 2022
Timor-Leste
95.0%
in 2022
Saudi Arabia rank
20th
Timor-Leste rank
18th
Treatment success rate for patients treated for MDR-TB over time
- Saudi Arabia
- Timor-Leste
How they compare
Timor-Leste currently reports 95.0% against 93.0% in Saudi Arabia, a difference of 2.0%.
The two have swapped places 3 times across 11 shared years of data; in 2009 it was Saudi Arabia ahead.
Saudi Arabia ranks 20th and Timor-Leste ranks 18th of 163 countries.
Across the 3 decades both report, Saudi Arabia averaged higher in 1 and Timor-Leste in 2.
Head to head by decade
| Decade | Saudi Arabia | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.0% | 0.0% | 33.0% | Saudi Arabia |
| 2010s | 59.4% | 78.6% | 19.1% | Timor-Leste |
| 2020s | 81.0% | 86.7% | 5.7% | Timor-Leste |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Saudi Arabia or Timor-Leste?
- Timor-Leste, at 95.0% against 93.0% in Saudi Arabia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Saudi Arabia and Timor-Leste?
- 2.0%, with Timor-Leste ahead.
- How many years of comparable data are there for Saudi Arabia and Timor-Leste?
- 11 years are reported by both, from 2009 to 2022.
- How do Saudi Arabia and Timor-Leste rank globally for treatment success rate for patients treated for mdr-tb?
- Saudi Arabia ranks 20th and Timor-Leste ranks 18th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.